Directors and Auditors Re-appointed at Advanced Enzyme Technologies Ltd.'s Annual General Meeting
Members of Advanced Enzyme Technologies Limited (AETL) approved key resolutions related to the appointment and re-appointment of senior management and statutory auditors at its 37th Annual General Meeting (AGM), held on July 31, 2026. The AGM confirmed the tenure for several critical roles within the company structure.The meeting results, which were ratified by scrutinizer’s report, detailed the continuation of leadership across various functions. Mr. Mukund Madhusudan Kabra was re-appointed as a Whole Time Director for another five years. This appointment is effective from April 01, 2027, extending until March 31, 2032.
In addition to the re-appointment of existing personnel, the company also appointed Mr. Pradip Bhailal Shah as an Independent Director. The tenure for Mr. Shah is set for five consecutive years, concluding on June 11, 2031.
The AGM also approved the re-appointment of M S K A & Associates LLP, Chartered Accountants, to serve as the Statutory Auditors of Advanced Enzyme Technologies Limited. This audit mandate covers a second term spanning five consecutive years. The tenure begins from the conclusion of the 37th AGM and runs until the conclusion of the company’s 42nd AGM, covering the financial year ended March 31, 2031.
The outcomes of these appointments and re-appointments are summarized below:
| Role | Name/Entity | Type of Appointment | Term Duration | Effective Dates |
|---|---|---|---|---|
| Whole Time Director | Mr. Mukund Madhusudan Kabra | Re-appointment | Five Years | April 01, 2027 to March 31, 2032 |
| Independent Director | Mr. Pradip Bhailal Shah | Appointment | Five Years | Up to June 11, 2031 |
| Statutory Auditors | M S K A & Associates LLP | Re-appointment | Five Years | From conclusion of 37th AGM until 42nd AGM (Financial year ended March 31, 2031) |
ADVENZYMES Stock Price Movement
Advanced Enzyme Technologies Limited shares rallied on Friday, closing up 3.20% to settle at ₹315.10. The stock saw strong activity during the session, with a total traded volume of 234,021 shares recorded as the equity finished higher.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.